How many studies have been conducted on Thymopentin?

BiohacksAI has indexed 300 PubMed studies on Thymopentin, including 34 randomized controlled trials (RCTs). 40% of studies involve human subjects.

What are the main research areas for Thymopentin?

The primary research domains for Thymopentin are 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Thymopentin

the amino acids 32-36 of thymopoietin and exhibiting the full biological activity of the natural hormone. It is an immunomodulator which has been studied for possible use in the treatment of rheumatoid arthritis, AIDS, and other primary immunodeficiencies.

300+ PubMed studies analyzed · 34 RCTs · Evidence Score: 47.1

Research Domains

Thymopentin has been studied across 17 research domains including 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation, ✨ Skin & Hair, 🦴 Bone & Joint. The primary research focus is 🛡️ Immunity with 26% of studies addressing this area.

Loading evidence profile...

This evidence profile for Thymopentin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.